AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

XTL Biopharmaceuticals Ltd.

Foreign Filer Report Mar 21, 2006

7116_rns_2006-03-21_e668f45b-0fe3-4c50-ad89-506b5b91b954.htm

Foreign Filer Report

Open in Viewer

Opens in native device viewer

C001 ��� �� �� ������������� ��"� 2
Public X T L BIOPHARMACEUTICALS LTD
4313 Corporation no: 520039470
Stock Exchange/Market: ��� �� ��
1996
379 Hasapir 3 , Nes Ziona 76100 , ,
Tel: 08-9304444 , Fax: 08-9304445
E.mail address: [email protected] Date of transmission: 21/03/2006
Time of broadcast: 09:00 08:58:40
Reference: 2006-02-026218
Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Financial Results for the year ended 31 December, 2005
04-06Financials_20_Mar_06_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 21/02/2006
- - -
Name of the Signatory : Kantor Ronen , , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary
Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.